-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
-
Summary
-
Apogee Therapeutics, Inc. annual and quarterly Net Cash Provided by (Used in) Financing Activities in USD history and change rate from 31 Dec 2022 to 31 Dec 2025.
- Apogee Therapeutics, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending 31 Mar 2025 was $622,000.
- Apogee Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2025 was $396,490,000, a 20% decline from 2024.
- Apogee Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2024 was $495,109,000, a 57% increase from 2023.
- Apogee Therapeutics, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $315,391,000, a 87% increase from 2022.